o morzu BEZ CENZURY! - opinie internautów

[thomassins]

An overactive bladder (OAB) is a common and bothersome condition, defined as the sudden, involuntary and frequent urge to urinate. OAB can be caused by a variety of different underlying conditions and can have a major impact on daily life. People who have OAB may experience sudden urges to urinate even when the bladder is not full, frequent and urgent need to urinate, difficulty starting and stopping urination, and frequent nighttime urination.

The exact cause of OAB is unknown, but it is thought to be due to a combination of factors, including an overactive bladder muscle, an overactive bladder nerve, or a combination of both. OAB can also be caused by a medical condition, such as an obstruction of the urinary tract, a urinary tract infection, or a neurological disorder. OAB can also be the result of lifestyle choices, such as drinking too much caffeine or alcohol, smoking, or not drinking enough water.

The most common symptom of OAB is the sudden, involuntary and frequent urge to urinate. People with OAB may find that they need to urinate more than 8 times a day, or more than 2 times a night.

Myrbetriq is a brand name for the drug known as mirabegron, an oral medication prescribed for the treatment of overactive bladder. It is the first and only drug of its kind to be approved by the U.S. Food and Drug Administration (FDA) for this condition. As such, it is seen as a breakthrough treatment and has become a popular choice among physicians and patients alike. However, many are asking why is myrbetriq so expensive?

The answer to this question has multiple layers. First and foremost, Myrbetriq is a brand-name drug, which is more expensive than its generic counterparts. Brand-name drugs are regulated by the FDA and must meet certain standards before they can be approved for sale. This includes rigorous testing and clinical trials, which can be costly and time-consuming. Also, brand-name drugs typically have higher research and development costs associated with them.

In addition, Myrbetriq is a patented drug, meaning that the manufacturer has exclusive rights to manufacture and market the drug. This means that the manufacturer can charge higher prices for the drug, as it is the only one available.